Recall Record

Langhorne, PA, United States

Insight Pharmaceuticals Corporation recalls

1 recall recorded since 2018, most recently on 22 November 2023. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)1

Completed Class I Drugs

Recall started
22 November 2023
Reason
Chemical Contamination; presence of benzene.
Distribution
Nationwide and Puerto Rico
Initiated
Voluntary: Firm initiated
Recall number
D-0151-2024

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.